GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Total Long-Term Liabilities

Orchid Pharma (NSE:ORCHPHARMA) Total Long-Term Liabilities : ₹1,244 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Orchid Pharma's Total Long-Term Liabilities for the quarter that ended in Mar. 2024 was ₹1,244 Mil.

Orchid Pharma Total Long-Term Liabilities Historical Data

The historical data trend for Orchid Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Total Long-Term Liabilities Chart

Orchid Pharma Annual Data
Trend Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,189.82 4,422.63 2,224.04 1,646.66 1,244.34

Orchid Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,646.66 - 1,452.32 - 1,244.34

Orchid Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Orchid Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchid Pharma (NSE:ORCHPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Total Long-Term Liabilities
Comparable Companies
NSE:RPGLIFE BOM:524164 BOM:512529 BOM:509079 BOM:530549 BOM:532612 BOM:590006 BOM:500288 BOM:500672 BOM:506690 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
524372:India
Address
313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034
Website
http://www.orchidpharma.com
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines